Clinical Trials Browser

Phase 2 × Cardiotoxicity × Metformin × Clear all

NCT02472353 2019-10-16

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Phase 2 Terminated

30 enrolled 10 charts

Breast Neoplasms, Neoplasms, Cardiotoxicity